Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pfizer claims MTP/apo B secretion inhibitors for use in obesity and related disorders

Feb. 12, 2003

Four series of tyrosine kinase inhibitors identified at Ariad

Feb. 12, 2003

Merck researchers describe new DPP-IV inhibitors for diabetes and other disorders

Feb. 11, 2003

Medtronic to exclusively market rhBMP-2 in Europe

Feb. 10, 2003

Preoperative epoetin alfa reduces blood transfusion requirement in knee or hip arthroplasty

Feb. 10, 2003

Kissei scientists design new series of SGLT-2 inhibitors

Feb. 10, 2003

Takeda designs new antidiabetic agents

Feb. 10, 2003

Effective dose of darbepoetin alfa for increasing preoperative hemoglobin levels

Feb. 10, 2003

AOD-9604 progresses in clinic

Feb. 5, 2003

Northfield submits response to FDA regarding PolyHeme phase III trial

Feb. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...